Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest
NCT: NCT06672159 · RECRUITING
Brief Summary
Double Sequential External Defibrillation (DSED) represents an alternative treatment of refractory ventricular fibrillation (rVF) in out-of-hospital cardiac arrest (OHCA). The procedure consists of two defibrillators that administer shocks at the same time. Currently, the procedure is not initiated before at least three failed attempts with one defibrillator. This can delay the potential benefits of establishing DSED earlier in the treatment. Studies have shown that early defibrillation is crucial for survival in OHCA patients, and in 2022, a clinical trial showed that survival in patients treated with DSED was higher compared to standard treatment. The effect of initiating OHCA treatment is unknown. The DUALDEFIB trial seeks to investigate if treating OHCA patients with DSED as an initial treatment will increase survival and provide improved neurological outcome.
Frequently Asked Questions
What is Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest?
Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest is a clinical trial registered under NCT06672159. Current status: RECRUITING.
What is the status of NCT06672159?
The current status of NCT06672159 (Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest) is: RECRUITING.
When did Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest start?
Initial Double Sequential External Defibrillation in Out of Hospital Cardiac Arrest started on 2025-04-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.